Clinical and financial evaluation of carbetocin as postpartum haemorrhage prophylaxis at caesarean section: A retrospective cohort study

ConclusionsCarbetocin reduced moderate blood loss>500  mL, but not PPH ≥1000 mL. Carbetocin conferred a 20% reduction in secondary uterotonic treatment, as well as lowering direct medical costs.

Source: The Australian and New Zealand Journal of Obstetrics and Gynaecology - November 9, 2018 Category: OBGYN Authors: Jemma Wohling, Nicole Edge, David Pena ‐Leal, Rui Wang, Ben Willem Mol, Gustaaf Dekker Tags: Original Article Source Type: research